HAVCR2 and cancer: Aberrant expression of Tim-3 has been reported to boost tumor progression and to be associated with unfavorable prognosis in many types of cancers (Piao et al., 2014; Yan et al., 2015; Zheng et al., 2015; Tawk et al., 2016; Zhang et al., 2019).